Meningococcal Infection: Prevalence, Vaccination, and Risk Factors

MENINGOCOCCAL INFECTION PREVALENCE IN TASMANIA
• A study by Lawrence et al. (2016), the health department of
Australia suggested that 10 % of the indigenous individuals in
Tasmania are carrying Neisseria meningitis in their nose and throat.
• The Australia childhood immunization registry shows Tasmania's
immunization rate for children aged 12 to 15 is just below 93% that
indicated that majority of the children are deprived of protection
from the immunity (Leeds et al. 2018).
• The immunization coverage rates for the individuals between 24 to
27 months decreased to 89%. The primary health of Tasmania
estimated that vaccination rates may vary from 67% to 88% in
some of the community
• The Australia childhood immunization registry shows Tasmania's
immunization rate for children aged 12 to 15 is just below 93% that
indicated that majority of the children are deprived of protection
from the immunity (Leeds et al. 2018)
figure: prevalence in Tasmania
source: (Leeds et al. 2018).
• Meningococcal meningitis is a rare but serious bacterial
infection caused by Neisseria meningitis that causes the
membrane that covered the brain and spinal cord become
inflamed
• The prevalence of the disease is recently observed in Tasmania
because of a frequent case of meningococcal infection amongst
aboriginal pollution in the middle of 2018 which is still running
spreading in that area
figure: meningitis
source: (Arnotte. et al. 2018).
RISK FACTORS
• A study by Rashid et al. (2015), suggested that older teenagers in
between 15 years to 21 years are particularly at risk of carrying
the bacteria and transmitting it to others
• Exposure to the smoking
• Infectious individuals
• throat discharge of individual carrying bacteria
figure: meningitis
FACILITIES AVAILABLE FOR THE
VACCINATIONS
REFERENCE:
• . A, C, Y, W vaccinations are available free of cost in
community care of aboriginal region of Tasmania and
the vaccination program would be conducted twice a
week in the community care setting with the
assistance of the general practitioner (Drew et al.
2018).
• Only vaccination B is available in the private
healthcare sectors and each of the vaccination cost $
150 that aboriginal individuals cannot afford (Arnotte.
et al. 2018).
• Apart from the vaccination, the additional
educational session would be given to each individual
in the community about the risk factor of the disease,
how vaccination help to 5educe it. It will help in
reducing health issues and empower patients to live
quality lives.
figure:vaccination
source: (Leeds et al. 2018).
Drew, N., Burns, J., Burrow, S., Elwell, M., Fleay, J.J., Gray, C., Harford-Mills, M., Hoareau, J.,
Macrae, A., Potter, C. and Poynton, M., 2018. Overview of Aboriginal and Torres Strait Islander
health status, 2017.
Rashid, H., Khatami, A., Haworth, E. and Booy, R., 2015. Meningococcal vaccination and Hajj
pilgrimage. The Lancet, 385(9973), pp.1072-1073
Leeds, I.L., Thayer, W.M., Sankhla, P., Bamogo, A. and Namasivayam, V., 2018. Mandatory
Meningococcal Serogroup B Vaccination for College Students is Not Cost-Effective. Value in
Health, 21, p.S1.
.